BridgeMD
New treatment option for COVID-19
Official title Severe COVID-19 Infection in Children Presenting to EDs in Israel and England
ClinicalTrials.gov ID: NCT06434701
What this study is testing
- What it's testing
- Even though the COVID-19 pandemic is no longer at its peak, the threat still lingers. Engaging in prospective surveillance studies will enable us to monitor the disease and prepare for any potential resurgence.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 16
You may be able to join if
- SACI Patients aged 16 years or younger with a positive COVID-19 PCR nasopharyngeal swab testing or bronchoalveolar sample who meet the definition of...
- Receive oxygen via low-flow nasal cannula or oxygen mask, high-flow nasal cannula, bilevel or continuous positive airway pressure machine, mechanical...
- Admitted to ICU
- MIS-C Patients aged 16 years or younger diagnosed with MIS-C
The study team makes the final eligibility decision.
Where it's taking place
- Afula, Israel
- Beersheba, Israel
- Jerusalem, Israel
- Kfar Saba, Israel
- Tel Litwinsky, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Afula, Israel; Beersheba, Israel; Jerusalem, Israel; Kfar Saba, Israel; Tel Litwinsky, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.